Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.


BACKGROUND Patients with metastatic breast cancer (MBC) are increasingly exposed to anthracyclines and taxanes either during treatment of primary breast cancer or during initial therapy of metastatic disease. The combination of gemcitabine and carboplatin was therefore investigated as an anthracycline- and taxane-free treatment option. PATIENTS AND… (More)
DOI: 10.1159/000136796

7 Figures and Tables


  • Presentations referencing similar topics